Table 2.
Variables | Categories | Frequency | Percent |
---|---|---|---|
Duration on ART | <12 months | 213 | 63.96 |
≥12 months | 120 | 36.04 | |
Last CD4 count | <350 cells/mm3 | 155 | 46.55 |
≥350 cells/mm3 | 178 | 53.45 | |
Current WHO clinical stage | Stage I | 125 | 37.54 |
Stage II | 67 | 20.12 | |
Stage III | 117 | 35.14 | |
Stage IV | 24 | 7.21 | |
Current functional status | Working | 273 | 81.98 |
Ambulatory | 40 | 12.01 | |
Bedridden | 20 | 6.01 | |
Active tuberculosis | Yes | 96 | 28.83 |
No | 237 | 71.17 | |
Cotrimoxazole preventive therapy | Yes | 200 | 60.06 |
No | 133 | 39.94 | |
Isoniazid preventive therapy | Yes | 225 | 67.57 |
No | 108 | 32.43 | |
ART adherence in the past month | <95% | 90 | 27.03 |
≥95% | 243 | 72.97 | |
Initial regimen changed | Yes | 26 | 7.81 |
No | 307 | 92.19 |